2614. Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial.
作者: Laurent Macle.;Paul Khairy.;Rukshen Weerasooriya.;Paul Novak.;Atul Verma.;Stephan Willems.;Thomas Arentz.;Isabel Deisenhofer.;George Veenhuyzen.;Christophe Scavée.;Pierre Jaïs.;Helmut Puererfellner.;Sylvie Levesque.;Jason G Andrade.;Lena Rivard.;Peter G Guerra.;Marc Dubuc.;Bernard Thibault.;Mario Talajic.;Denis Roy.;Stanley Nattel.; .
来源: Lancet. 2015年386卷9994期672-9页
Catheter ablation is increasingly used to manage atrial fibrillation, but arrhythmia recurrences are common. Adenosine might identify pulmonary veins at risk of reconnection by unmasking dormant conduction, and thereby guide additional ablation to improve arrhythmia-free survival. We assessed whether adenosine-guided pulmonary vein isolation could prevent arrhythmia recurrence in patients undergoing radiofrequency catheter ablation for paroxysmal atrial fibrillation.
2615. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
The optimal ways of using aromatase inhibitors or tamoxifen as endocrine treatment for early breast cancer remains uncertain.
2616. A medical-toxicological view of tattooing.
作者: Peter Laux.;Tewes Tralau.;Jutta Tentschert.;Annegret Blume.;Sascha Al Dahouk.;Wolfgang Bäumler.;Eric Bernstein.;Beatrice Bocca.;Alessandro Alimonti.;Helen Colebrook.;Christa de Cuyper.;Lars Dähne.;Urs Hauri.;Paul C Howard.;Paul Janssen.;Linda Katz.;Bruce Klitzman.;Nicolas Kluger.;Lars Krutak.;Thomas Platzek.;Victoria Scott-Lang.;Jørgen Serup.;Wera Teubner.;Ines Schreiver.;Elena Wilkniß.;Andreas Luch.
来源: Lancet. 2016年387卷10016期395-402页
Long perceived as a form of exotic self-expression in some social fringe groups, tattoos have left their maverick image behind and become mainstream, particularly for young people. Historically, tattoo-related health and safety regulations have focused on rules of hygiene and prevention of infections. Meanwhile, the increasing popularity of tattooing has led to the development of many new colours, allowing tattoos to be more spectacular than ever before. However, little is known about the toxicological risks of the ingredients used. For risk assessment, safe intradermal application of these pigments needs data for toxicity and biokinetics and increased knowledge about the removal of tattoos. Other concerns are the potential for phototoxicity, substance migration, and the possible metabolic conversion of tattoo ink ingredients into toxic substances. Similar considerations apply to cleavage products that are formed during laser-assisted tattoo removal. In this Review, we summarise the issues of concern, putting them into context, and provide perspectives for the assessment of the acute and chronic health effects associated with tattooing.
2618. Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Bisphosphonates have profound effects on bone physiology, and could modify the process of metastasis. We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer.
|